Projects

Metabolic engineering of human gut microbiome for improved micronutrient status – a Proof-of- Concept using stable isotopic probes

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2025 - 2026

Project Lead

Dr. Shalini G Hegde

Authors

Dr. Shalini G Hegde

Project Status

ongoing

Project Type

The First in the world grant (ICMR)